Literature DB >> 19796411

Performance of maximum inspiratory pressure tests and maximum inspiratory pressure reference equations for 4 race/ethnic groups.

Michael C Sachs1, Paul L Enright, Karen D Hinckley Stukovsky, Rui Jiang, R Graham Barr.   

Abstract

BACKGROUND: Maximum inspiratory pressure (MIP) is an important and noninvasive index of diaphragm strength and an independent predictor of all-cause mortality. The ability of adults over a wide age range and multiple race/ethnicities to perform MIP tests has previously not been evaluated.
METHODS: The Multi-Ethnic Study of Atherosclerosis recruited white, African American, Hispanic, and Chinese American participants, ages 45-84 years, and free of clinical cardiovascular disease in 6 United States cities. MIP was measured using standard techniques among 3,849 Multi-Ethnic Study of Atherosclerosis participants. The MIP quality goal was 5 maneuvers, with the 2 largest values matching within 10 cm H2O. Correlates of MIP quality and values were assessed in logistic and linear regression models.
RESULTS: The 3,849 participants with MIP measures were 51% female, 35% white, 26% African American, 23% Hispanic, and 16% Chinese American. Mean+/-SD MIP was 73+/-26 cm H2O for women and 97+/-29 cm H2O for men. The quality goal was achieved by 83% of the cohort and was associated with female sex, older age, race/ethnicity, study site, low ratio of forced expiratory volume in the first second to forced vital capacity (FEV1/FVC), and wheeze with dyspnea. The multivariate correlates of MIP were male sex, younger age, higher body mass index, shorter height, higher FVC, higher systolic blood pressure (in women) and health status (in men). There were no clinically important race/ethnic differences in MIP values.
CONCLUSIONS: Race-specific reference equations for MIP are unnecessary in the United States. More than 80% of adults can be successfully coached for 5 maneuvers, with repeatability within 10 cm H2O.

Entities:  

Mesh:

Year:  2009        PMID: 19796411      PMCID: PMC3616895     

Source DB:  PubMed          Journal:  Respir Care        ISSN: 0020-1324            Impact factor:   2.258


  15 in total

Review 1.  Disorders of the respiratory muscles.

Authors:  Franco Laghi; Martin J Tobin
Journal:  Am J Respir Crit Care Med       Date:  2003-07-01       Impact factor: 21.405

2.  Standardisation of spirometry.

Authors:  M R Miller; J Hankinson; V Brusasco; F Burgos; R Casaburi; A Coates; R Crapo; P Enright; C P M van der Grinten; P Gustafsson; R Jensen; D C Johnson; N MacIntyre; R McKay; D Navajas; O F Pedersen; R Pellegrino; G Viegi; J Wanger
Journal:  Eur Respir J       Date:  2005-08       Impact factor: 16.671

3.  Maximal static respiratory pressures in adults: normal values and their relationship to determinants of respiratory function.

Authors:  W Vincken; H Ghezzo; M G Cosio
Journal:  Bull Eur Physiopathol Respir       Date:  1987 Sep-Oct

4.  Maximal inspiratory pressure: does reproducibility indicate full effort?

Authors:  T K Aldrich; P Spiro
Journal:  Thorax       Date:  1995-01       Impact factor: 9.139

5.  How many maneuvers are required to measure maximal inspiratory pressure accurately.

Authors:  A S Wen; M S Woo; T G Keens
Journal:  Chest       Date:  1997-03       Impact factor: 9.410

6.  Respiratory muscle strength in the elderly. Correlates and reference values. Cardiovascular Health Study Research Group.

Authors:  P L Enright; R A Kronmal; T A Manolio; M B Schenker; R E Hyatt
Journal:  Am J Respir Crit Care Med       Date:  1994-02       Impact factor: 21.405

7.  Measurement of respiratory muscle forces based on maximal inspiratory and expiratory pressures.

Authors:  J Karvonen; S Saarelainen; M M Nieminen
Journal:  Respiration       Date:  1994       Impact factor: 3.580

8.  Maximal inspiratory pressure. Learning effect and test-retest reliability in patients with chronic obstructive pulmonary disease.

Authors:  J L Larson; M K Covey; C A Vitalo; C G Alex; M Patel; M J Kim
Journal:  Chest       Date:  1993-08       Impact factor: 9.410

9.  Spirometry and maximal respiratory pressure references from healthy Minnesota 65- to 85-year-old women and men.

Authors:  P L Enright; A B Adams; P J Boyle; D L Sherrill
Journal:  Chest       Date:  1995-09       Impact factor: 9.410

10.  Multi-Ethnic Study of Atherosclerosis: objectives and design.

Authors:  Diane E Bild; David A Bluemke; Gregory L Burke; Robert Detrano; Ana V Diez Roux; Aaron R Folsom; Philip Greenland; David R Jacob; Richard Kronmal; Kiang Liu; Jennifer Clark Nelson; Daniel O'Leary; Mohammed F Saad; Steven Shea; Moyses Szklo; Russell P Tracy
Journal:  Am J Epidemiol       Date:  2002-11-01       Impact factor: 4.897

View more
  25 in total

1.  Antihypertensive medications and physical function in older persons.

Authors:  Carlos A Vaz Fragoso; Gail J McAvay
Journal:  Exp Gerontol       Date:  2020-06-25       Impact factor: 4.032

2.  Mitochondrial DNA variants and pulmonary function in older persons.

Authors:  Carlos A Vaz Fragoso; Todd M Manini; John A Kairalla; Thomas W Buford; Fang-Chi Hsu; Thomas M Gill; Stephen B Kritchevsky; Mary M McDermott; Jason L Sanders; Steven R Cummings; Gregory J Tranah
Journal:  Exp Gerontol       Date:  2018-12-01       Impact factor: 4.032

3.  Repeated-sprint cycling does not induce respiratory muscle fatigue in active adults: measurements from the powerbreathe® inspiratory muscle trainer.

Authors:  Clare Minahan; Beth Sheehan; Rachel Doutreband; Tom Kirkwood; Daniel Reeves; Troy Cross
Journal:  J Sports Sci Med       Date:  2015-03-01       Impact factor: 2.988

4.  Heterogeneity of healthy aging: comparing long-lived families across five healthy aging phenotypes of blood pressure, memory, pulmonary function, grip strength, and metabolism.

Authors:  Megan M Marron; Mary K Wojczynski; Ryan L Minster; Robert M Boudreau; Paola Sebastiani; Stephanie Cosentino; Bharat Thyagarajan; Svetlana V Ukraintseva; Nicole Schupf; Kaare Christensen; Mary Feitosa; Thomas Perls; Joseph M Zmuda; Anne B Newman
Journal:  Geroscience       Date:  2019-07-22       Impact factor: 7.713

5.  Respiratory impairment and dyspnea and their associations with physical inactivity and mobility in sedentary community-dwelling older persons.

Authors:  Carlos A Vaz Fragoso; Daniel P Beavers; John L Hankinson; Gail Flynn; Kathy Berra; Stephen B Kritchevsky; Christine K Liu; Mary M McDermott; Todd M Manini; W Jack Rejeski; Thomas M Gill
Journal:  J Am Geriatr Soc       Date:  2014-03-17       Impact factor: 5.562

Review 6.  Respiratory impairment and the aging lung: a novel paradigm for assessing pulmonary function.

Authors:  Carlos A Vaz Fragoso; Thomas M Gill
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2011-12-01       Impact factor: 6.053

7.  Effect of Structured Physical Activity on Respiratory Outcomes in Sedentary Elderly Adults with Mobility Limitations.

Authors:  Carlos A Vaz Fragoso; Daniel P Beavers; Stephen D Anton; Christine K Liu; Mary M McDermott; Anne B Newman; Marco Pahor; Randall S Stafford; Thomas M Gill
Journal:  J Am Geriatr Soc       Date:  2016-03       Impact factor: 5.562

Review 8.  Reference values for maximal inspiratory pressure: a systematic review.

Authors:  Isabela M B Sclauser Pessoa; Verônica Franco Parreira; Guilherme A F Fregonezi; A William Sheel; Frank Chung; W Darlene Reid
Journal:  Can Respir J       Date:  2013-10-17       Impact factor: 2.409

9.  Correlation and Predicted Equations of MIP/MEP from the Pulmonary Function, Demographics and Anthropometrics in Healthy Thai Participants aged 19 to 50 Years.

Authors:  Thanyaluck Sriboonreung; Jirakrit Leelarungrayub; Araya Yankai; Rungthip Puntumetakul
Journal:  Clin Med Insights Circ Respir Pulm Med       Date:  2021-03-22

10.  Associations between muscle strength, spirometric pulmonary function and mobility in healthy older adults.

Authors:  E Sillanpää; L Stenroth; A Y Bijlsma; T Rantanen; J S McPhee; T M Maden-Wilkinson; D A Jones; M V Narici; H Gapeyeva; M Pääsuke; Y Barnouin; J-Y Hogrel; G S Butler-Browne; C G M Meskers; A B Maier; T Törmäkangas; S Sipilä
Journal:  Age (Dordr)       Date:  2014-07-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.